Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia

Alpha‐synucleinopathies (ASP) are neurodegenerative disorders, characterized by accumulation of misfolded α‐synuclein, selective neuronal loss, and extensive gliosis. It is accepted that microgliosis and astrogliosis contribute to the disease progression in ASP. Toll‐like receptors (TLRs) are expressed on cells of the innate immune system, including glia, and TLR4 dysregulation may play a role in ASP pathogenesis. In this study we aimed to define the involvement of TLR4 in microglial and astroglial activation induced by different forms of α‐synuclein (full length soluble, fibrillized, and C‐terminally truncated). Purified primary wild type (TLR4+/+) and TLR4 deficient (TLR4−/−) murine microglial and astroglial cell cultures were treated with recombinant α‐synuclein and phagocytic activity, NFκB nuclear translocation, cytokine release, and reactive oxygen species (ROS) production were measured. We show that TLR4 mediates α‐synuclein‐induced microglial phagocytic activity, pro‐inflammatory cytokine release, and ROS production. TLR4−/− astroglia present a suppressed pro‐inflammatory response and decreased ROS production triggered by α‐synuclein treatment. However, the uptake of α‐synuclein by primary astroglia is not dependent on TLR4 expression. Our results indicate the C‐terminally truncated form as the most potent inductor of TLR4‐dependent glial activation. The current findings suggest that TLR4 plays a modulatory role on glial pro‐inflammatory responses and ROS production triggered by α‐synuclein. In contrast to microglia, the uptake of alpha‐synuclein by astroglia is not dependent on TLR4. Our data provide novel insights into the mechanisms of α‐synuclein‐induced microglial and astroglial activation which may have an impact on understanding the pathogenesis of ASP. © 2012 Wiley Periodicals, Inc.

[1]  Seung-Jae Lee,et al.  Alpha-synuclein stimulation of astrocytes Potential role for neuroinflammation and neuroprotection , 2014 .

[2]  E. Richfield,et al.  Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease , 2012, Brain pathology.

[3]  R. Ransohoff,et al.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration , 2011, Nature Neuroscience.

[4]  W. Poewe,et al.  Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons. , 2011, The American journal of pathology.

[5]  K. Jellinger,et al.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts , 2011, Acta Neuropathologica.

[6]  J. Cooper,et al.  Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line , 2011, Neuroscience Research.

[7]  A. Planas,et al.  Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88‐dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways , 2011, Glia.

[8]  G. Halliday,et al.  Glia: Initiators and progressors of pathology in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[9]  N. El-Hage,et al.  Toll-like Receptor Expression and Activation in Astroglia: Differential Regulation by HIV-1 Tat, gp120, and Morphine , 2011, Immunological investigations.

[10]  K. Tieu,et al.  Astrocytes and therapeutics for Parkinson’s disease , 2010, Neurotherapeutics.

[11]  C. Combs,et al.  Expression of mutant alpha-synuclein modulates microglial phenotype in vitro , 2011, Journal of Neuroinflammation.

[12]  C. Dobson,et al.  Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants , 2010, PloS one.

[13]  Hee-Sun Kim,et al.  α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1 , 2010, The Journal of Immunology.

[14]  Ana M. Blanco,et al.  Pivotal Role of TLR4 Receptors in Alcohol-Induced Neuroinflammation and Brain Damage , 2010, The Journal of Neuroscience.

[15]  E. Gundelfinger,et al.  Contributions of astrocytes to synapse formation and maturation — Potential functions of the perisynaptic extracellular matrix , 2010, Brain Research Reviews.

[16]  E. Masliah,et al.  Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.

[17]  S. Lehnardt,et al.  Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury , 2009, Glia.

[18]  G. Landreth,et al.  CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation , 2009, The Journal of Neuroscience.

[19]  T. Gasser Molecular pathogenesis of Parkinson disease: insights from genetic studies , 2009, Expert Reviews in Molecular Medicine.

[20]  David Park,et al.  Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.

[21]  W. Schulz-Schaeffer,et al.  Screening of innate immune receptors in neurodegenerative diseases: A similar pattern , 2009, Neurobiology of Aging.

[22]  Sonja W. Scholz,et al.  SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.

[23]  F. Gage,et al.  A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death , 2009, Cell.

[24]  Sung-Chun Tang,et al.  Toll-like receptors in neurodegeneration , 2009, Brain Research Reviews.

[25]  R. Koehler,et al.  Astrocytes and the regulation of cerebral blood flow , 2009, Trends in Neurosciences.

[26]  Xiaomin Su,et al.  Synuclein activates microglia in a model of Parkinson's disease , 2008, Neurobiology of Aging.

[27]  He-Jin Lee,et al.  Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. , 2008, Biochemical and biophysical research communications.

[28]  P. Mcgeer,et al.  α-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia , 2008, Neurobiology of Aging.

[29]  H. Gendelman,et al.  Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities , 2008, Journal of Neuroimmune Pharmacology.

[30]  W. Poewe,et al.  Microglial activation mediates neurodegeneration related to oligodendroglial α‐synucleinopathy: Implications for multiple system atrophy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[31]  Jing Zhang,et al.  Identification of proteins involved in microglial endocytosis of alpha-synuclein. , 2007, Journal of proteome research.

[32]  S. Rivest,et al.  Neuroprotective role of the innate immune system by microglia , 2007, Neuroscience.

[33]  S. G. Bolder,et al.  Thioflavin T and birefringence assays to determine the conversion of proteins into fibrils. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[34]  Jing Zhang,et al.  Identification of proteins involved in microglial endocytosis of alpha-synuclein. , 2007, Journal of Proteome Research.

[35]  Milos Pekny,et al.  Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury , 2006, Proceedings of the National Academy of Sciences.

[36]  Colin K. Combs,et al.  α-Synuclein Expression Modulates Microglial Activation Phenotype , 2006, The Journal of Neuroscience.

[37]  Andis Klegeris,et al.  Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[39]  T. Kielian Toll‐like receptors in central nervous system glial inflammation and homeostasis , 2006, Journal of neuroscience research.

[40]  Alexander Hammers,et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.

[41]  Paul R. Carey,et al.  Secondary Structure of α-Synuclein Oligomers: Characterization by Raman and Atomic Force Microscopy , 2006 .

[42]  N. Maiti,et al.  Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. , 2006, Journal of molecular biology.

[43]  A. Floden,et al.  Alpha-synuclein expression modulates microglial activation phenotype. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  Makoto Hashimoto,et al.  Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy , 2005, The Journal of Neuroscience.

[45]  E. Hirsch,et al.  Neuroinflammatory processes in Parkinson's disease. , 2005, Parkinsonism & related disorders.

[46]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[47]  Belinda Wilson,et al.  Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  S. Miller,et al.  Differential activation of astrocytes by innate and adaptive immune stimuli , 2005, Glia.

[49]  Mari Yoshida,et al.  Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains , 2005, Acta Neuropathologica.

[50]  M. Simard,et al.  The neurobiology of glia in the context of water and ion homeostasis , 2004, Neuroscience.

[51]  Niall P Quinn,et al.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. , 2004, Brain : a journal of neurology.

[52]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[53]  I. Marriott,et al.  Cultured astrocytes express toll‐like receptors for bacterial products , 2003, Glia.

[54]  W. Poewe,et al.  Tumor necrosis factor‐α‐induced cell death in U373 cells overexpressing α‐synuclein , 2003 .

[55]  B. Liu,et al.  Synergistic Dopaminergic Neurotoxicity of the Pesticide Rotenone and Inflammogen Lipopolysaccharide: Relevance to the Etiology of Parkinson's Disease , 2003, The Journal of Neuroscience.

[56]  S. Hunot,et al.  Neuroinflammatory processes in Parkinson's disease , 2003, Annals of neurology.

[57]  Tom Misteli,et al.  In vivo imaging. , 2003, Methods.

[58]  W. Poewe,et al.  Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein. , 2003, Journal of neuroscience research.

[59]  W. Streit Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.

[60]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[61]  R. Nussbaum,et al.  Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein α-Synuclein* , 2002, The Journal of Biological Chemistry.

[62]  W. Poewe,et al.  Glial cell death induced by overexpression of α‐synuclein , 2001 .

[63]  W. Poewe,et al.  Glial cell death induced by overexpression of alpha-synuclein. , 2001, Journal of neuroscience research.

[64]  P. Lansbury,et al.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. , 2000, Biochemistry.

[65]  S. Hayashi,et al.  NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains , 2000, Acta Neuropathologica.

[66]  S. Hayashi,et al.  NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. , 2000, Acta neuropathologica.

[67]  J. Culvenor,et al.  α‐Synuclein Immunoisolation of Glial Inclusions from Multiple System Atrophy Brain Tissue Reveals Multiprotein Components , 1999, Journal of neurochemistry.

[68]  S. Jander,et al.  The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.

[69]  J Q Trojanowski,et al.  Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.